Advertisement

Gastrointestinal Infections After Solid Organ or Hematopoietic Cell Transplantation

  • Christopher J. Damman
  • George B. McDonald
Chapter

Abstract

The gastrointestinal tract is a common site of infection in patients who are immunosuppressed following either solid organ (SOT) or hematopoietic cell transplantation (HCT). Prophylactic regiments and screening have decreased the rate of infections, but despite these advances viruses, fungi, and bacteria continue to be a major cause of morbidity. In this chapter we first present a transplant-specific approach to gastrointestinal infections followed by a problem-oriented approach to gastrointestinal symptoms after transplant.

Keywords

Esophagitis Gastritis Enteritis Colitis Gastrointestinal symptoms Hematopoietic cell transplant Liver transplant Kidney transplant Heart transplant Lung transplant Intestinal transplant Pancreas transplant 

References

  1. 1.
    Kathuria P, Sakhuja V, Gupta KL, Jha V, Kochhar R, Joshi K, et al. Gastrointestinal complications after renal transplantation. 10 year data from a North Indian transplant center. ASAIO J. 1995;41(3):M698–703.PubMedCrossRefGoogle Scholar
  2. 2.
    Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol. 2002;13(1): 277–87.PubMedGoogle Scholar
  3. 3.
    Logan AJ, Morris-Stiff GJ, Bowrey DJ, Jurewicz WA. Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study. Clin Transplant. 2002;16(3):163–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):3–26.PubMedCrossRefGoogle Scholar
  5. 5.
    San Juan R, Aguado JM, Lumbreras C, Fortun J, Munoz P, Gavalda J, et al. RESITRA Network of the spanish study group of infection in transplantation. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation. Clin Infect Dis. 2008; 47(7):875–82.Google Scholar
  6. 6.
    The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation. 1996;61(7): 1029–37.CrossRefGoogle Scholar
  7. 7.
    Humar A, Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transplant. 2009;9 Suppl 4:S78–86.PubMedCrossRefGoogle Scholar
  8. 8.
    Beam E, Razonable RR. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment. Curr Infect Dis Rep. 2012;14(6):633–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Snydman DR, Limaye AP, Potena L, Zamora MR. Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc. 2011;43(3 Suppl):S1–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Smith C, Khanna R. Immune regulation of human herpesviruses and its implications for human transplantation. Am J Transplant. 2013;13 Suppl 3:9–23.PubMedCrossRefGoogle Scholar
  11. 11.
    Fishman JA. Overview: cytomegalovirus and the herpesviruses in transplantation. Am J Transplant. 2013;13 Suppl 3:1–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2010;10(1):157–61.PubMedCrossRefGoogle Scholar
  13. 13.
    Tilsed JV, Morgan JD, Veitch PS, Donnelly PK. Reactivation of duodenal cytomegalovirus infection mimicking a transplant lymphoma. Transplantation. 1992;54:945–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010;89(7):779–95.PubMedCrossRefGoogle Scholar
  15. 15.
    Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96(4):333–60.PubMedCrossRefGoogle Scholar
  16. 16.
    Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2013;2:CD003774.Google Scholar
  17. 17.
    Witzke O, Hauser IA, Bartels M, Wolf G, Wolters H, Nitschke M, et al. Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial. Transplantation. 2012;93(1):61–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Mengelle C, Rostaing L, Weclawiak H, Rossignol C, Kamar N, Izopet J. Prophylaxis versus pre‐emptive treatment for prevention of cytomegalovirus infection in CMV‐seropositive orthotopic liver‐transplant recipients. J Med Virol. 2015;87(5): 836–44.PubMedCrossRefGoogle Scholar
  19. 19.
    Snydman DR. Putting the IMPACT study into perspective: should CMV prophylaxis be extended to 6 months for high risk transplants? Am J Transplant. 2011;11(1):6–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Gerna G, Lilleri D, Furione M, Baldanti F. Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection. New Microbiol. 2011;34(3): 229–54.PubMedGoogle Scholar
  21. 21.
    Zuckerman RA, Limaye AP. Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients. Am J Transplant. 2013;13 Suppl 3:55–66.PubMedCrossRefGoogle Scholar
  22. 22.
    Fiddian P, Sabin CA, Griffiths PD. Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. J Infect Dis. 2002;186 Suppl 1:S110–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013;13 Suppl 3:41–54.PubMedCrossRefGoogle Scholar
  24. 24.
    Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet. 2000;355(9218):1886–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Agraharkar ML, Cinclair RD, Kuo YF, Daller JA, Shahinian VB. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int. 2004;66(1):383–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Tremblay F, Fernandes M, Habbab F, deB Edwardes MD, Loertscher R, Meterissian S. Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol. 2002;9(8):785–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003;89(7):1221–7.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Razonable RR. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant. 2013;13 Suppl 3:67–78.PubMedCrossRefGoogle Scholar
  29. 29.
    Lee LY, Ison MG. Diarrhea caused by viruses in transplant recipients. Transpl Infect Dis. 2014;16(3):347–58.PubMedCrossRefGoogle Scholar
  30. 30.
    Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013;369(13):1227–36.PubMedCrossRefGoogle Scholar
  31. 31.
    Echenique IA, Penugonda S, Stosor V, Ison MG, Angarone MP. Diagnostic yields in solid organ transplant recipients admitted with diarrhea. Clin Infect Dis. 2015;60(5):729–37.PubMedCrossRefGoogle Scholar
  32. 32.
    Tsapepas DS, Martin ST, Miao J, Shah SA, Scheffert J, Fester K, et al. Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center. Diagn Microbiol Infect Dis. 2015;81(4):299–304.PubMedCrossRefGoogle Scholar
  33. 33.
    Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis. 2008;197(3):435–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–30.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136(6):1913–24.PubMedCrossRefGoogle Scholar
  36. 36.
    Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–31.PubMedCrossRefGoogle Scholar
  37. 37.
    Surawicz CM, Alexander J. Treatment of refractory and recurrent Clostridium difficile infection. Nat Rev Gastroenterol Hepatol. 2011;8(6):330–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–71.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Mittal C, Miller N, Meighani A, Hart BR, John A, Ramesh M. Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma. Bone Marrow Transplant. 2015;50(7):1010.PubMedCrossRefGoogle Scholar
  40. 40.
    Goldberg EJ, Bhalodia S, Jacob S, Patel H, Trinh KV, Varghese B, et al. Clostridium difficile infection: a brief update on emerging therapies. Am J Health Syst Pharm. 2015;72(12): 1007–12.PubMedCrossRefGoogle Scholar
  41. 41.
    Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA. 2015;313(17): 1719–27.PubMedCrossRefGoogle Scholar
  42. 42.
    Espinosa-Aguilar L, Forrest GN. Candidiasis in solid organ transplantation. Infectious Disease and Antimicrobial Agents. www.antimicrobe.org/new/t06_ew.html.
  43. 43.
    Farmakiotis D, Kontoyiannis DP. Emerging issues with diagnosis and management of fungal infections in solid organ transplant recipients. Am J Transplant. 2015:n/a-n/a.Google Scholar
  44. 44.
    Gavaldà J, Meije Y, Fortún J, Roilides E, Saliba F, Lortholary O, et al. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20:27–48.PubMedCrossRefGoogle Scholar
  45. 45.
    Gumbo T, Hobbs RE, Carlyn C, Hall G, Isada CM. Microsporidia infection in transplant patients. Transplantation. 1999;67(3):482–4.PubMedCrossRefGoogle Scholar
  46. 46.
    DeVault GA, King JW, Rohr MS, Landreneau MD, Brown ST, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis. 1990;12(4):653–71.PubMedCrossRefGoogle Scholar
  47. 47.
    Sarkio S, Halme L, Kyllonen L, Salmela K. Severe gastrointestinal complications after 1,515 adult kidney transplantations. Transpl Int. 2004;17(9):505–10.PubMedCrossRefGoogle Scholar
  48. 48.
    Gil-Vernet S, Amado A, Ortega F, Alarcon A, Bernal G, Capdevila L, et al. Gastrointestinal complications in renal transplant recipients: MITOS study. Transplant Proc. 2007;39(7):2190–3.PubMedCrossRefGoogle Scholar
  49. 49.
    Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int. 2005;18(6):643–50.PubMedCrossRefGoogle Scholar
  50. 50.
    Andreoni KA, Pelletier RP, Elkhammas EA, Davies EA, Bumgardner GL, Henry ML, et al. Increased incidence of gastrointestinal surgical complications in renal transplant recipients with polycystic kidney disease. Transplantation. 1999; 67(2):262–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Dee SL, Butt K, Ramaswamy G. Intestinal ischemia. Arch Pathol Lab Med. 2002;126(10):1201–4.PubMedGoogle Scholar
  52. 52.
    Lowell JA, Stratta RJ, Taylor RJ, Bynon JS, Larsen JL, Nelson NL. Cholelithiasis in pancreas and kidney transplant recipients with diabetes. Surgery. 1993;114(4):858–63.PubMedGoogle Scholar
  53. 53.
    Moudgil A, Germain BM, Nast CC, Toyoda M, Strauss FG, Jordan SC. Ureteritis and cholecystitis: two unusual manifestations of cytomegalovirus disease in renal transplant recipients. Transplantation. 1997;64(7):1071–3.PubMedCrossRefGoogle Scholar
  54. 54.
    Badalamenti S, DeFazio C, Castelnovo C, Sangiovanni A, Como G, De Vecchi A, et al. High prevalence of silent gallstone disease in dialysis patients. Nephron. 1994;66(2): 225–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Berger N, Wirmsberger R, Kafka R, Margreiter C, Ebenbichler C, Stelzmueller I, et al. Infectious complications following 72 consecutive enteric-drained pancreas transplants. Transpl Int. 2006;19(7):549–57.PubMedCrossRefGoogle Scholar
  56. 56.
    Toupance O, Bouedjoro-Camus MC, Carquin J, Novella JL, Lavaud S, Wynckel A, et al. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses. Transpl Int. 2000;13(6):413–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Kunzle N, Petignat C, Francioli P, Vogel G, Seydoux C, Corpataux JM, et al. Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity. Transpl Infect Dis. 2000;2(3):118–26.PubMedCrossRefGoogle Scholar
  58. 58.
    Slifkin M, Tempesti P, Poutsiaka DD, Snydman DR. Late and atypical cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis. 2001;33(7):E62–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Rayes N, Seehofer D, Kahl A, Kokott S, Pratschke J, Frei U, et al. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis. Transpl Int. 2007;20(11):974–81.PubMedCrossRefGoogle Scholar
  60. 60.
    Boudreault AA, Xie H, Rakita RM, Scott JD, Davis CL, Boeckh M, et al. Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis. Transpl Infect Dis. 2011;13(3):244–9.PubMedCentralPubMedCrossRefGoogle Scholar
  61. 61.
    Ardalan MR, Etemadi J, Somi MH, Ghafari A, Ghojazadeh M. Upper gastrointestinal bleeding during the first month after renal transplantation in the mycophenolate mofetil era. Transplant Proc. 2009;41(7):2845–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Sarkio S, Rautelin H, Kyllonen L, Honkanen E, Salmela K, Halme L. Should helicobacter pylori infection be treated before kidney transplantation? Nephrol Dial Transplant. 2001;16(10):2053–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–51. see comments. [Review] [80 refs].PubMedCrossRefGoogle Scholar
  64. 64.
    Metge S, Van Nhieu JT, Dahmane D, Grimbert P, Foulet F, Sarfati C, et al. A case of Enterocytozoon bieneusi infection in an HIV-negative renal transplant recipient. Eur J Clin Microbiol Infect Dis. 2000;19(3):221–3.PubMedCrossRefGoogle Scholar
  65. 65.
    Mayoral JL, Loeffler CM, Fasola CG. Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. Arch Surg. 1991;126: 202–6.PubMedCrossRefGoogle Scholar
  66. 66.
    Frankel AH, Barker F, Williams G, Benjamin IS, Lechler R, Rees AJ. Neutropenic colitis in a renal transplant patient. Transplantation. 1991;52:913–4.PubMedCrossRefGoogle Scholar
  67. 67.
    Roncoroni AJ, Gomez MA, Mera J, Cagnoni P, Michel MD. Cryptosporidium infection in renal transplant patients. (Lett). J Infect Dis. 1989;160:559.PubMedCrossRefGoogle Scholar
  68. 68.
    Altiparmak MR, Trablus S, Pamuk ON, Apaydin S, Sariyar M, Ozturk R, et al. Diarrhoea following renal transplantation. Clin Transplant. 2002;16(3):212–6.PubMedCrossRefGoogle Scholar
  69. 69.
    Tavakoli A, Liong S. Pancreatic transplant in diabetes. Adv Exp Med Biol. 2012;771:420–37.PubMedGoogle Scholar
  70. 70.
    Tam N, Zhang C, Lin J, Wu C, Deng R, Liao B, et al. Simultaneous pancreas and kidney transplantation for liver transplant recipients with diabetes and uremia. Clin Res Hepatol Gastroenterol. 2015;39(3):399–404.PubMedCrossRefGoogle Scholar
  71. 71.
    Herrero-Martinez JM, Lumbreras C, Manrique A, San-Juan R, Garcia-Reyne A, Lopez-Medrano F, et al. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation. Clin Microbiol Infect. 2013;19(12):1132–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Sterling RK. Management of gastrointestinal disease in liver transplant recipients. Gastrointest Endosc Clin N Am. 2001;11(1):185–97.PubMedGoogle Scholar
  73. 73.
    Verdonk RC, Buis CI, Porte RJ, Haagsma EB. Biliary complications after liver transplantation: a review. Scand J Gastroenterol Suppl. 2006;243:89–101.CrossRefGoogle Scholar
  74. 74.
    Pedersen M, Seetharam A. Infections after orthotopic liver transplantation. J Clin Exp Hepatol. 2014;4(4):347–60.PubMedCentralPubMedCrossRefGoogle Scholar
  75. 75.
    Kim SI. Bacterial infection after liver transplantation. World J Gastroenterol. 2014;20(20):6211–20.PubMedCentralPubMedCrossRefGoogle Scholar
  76. 76.
    Chow JK, Werner BG, Ruthazer R, Snydman DR. Increased serum iron levels and infectious complications after liver transplantation. Clin Infect Dis. 2010;51(3):e16–23.PubMedCentralPubMedCrossRefGoogle Scholar
  77. 77.
    Milan A, Sampaio AM, Guardia AC, Pavan CR, Andrade PD, Bonon SH, et al. Identification of bacterial infections and clinical manifestation associated with cytomegalovirus in liver transplantation patients. Transplant Proc. 2013;45(3):1130–2.PubMedCrossRefGoogle Scholar
  78. 78.
    Bosch W, Heckman MG, Diehl NN, Shalev JA, Pungpapong S, Hellinger WC. Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients. Am J Transplant. 2011;11(10):2181–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Mukhtar A, Abdelaal A, Hussein M, Dabous H, Fawzy I, Obayah G, et al. Infection complications and pattern of bacterial resistance in living-donor liver transplantation: a multicenter epidemiologic study in Egypt. Transplant Proc. 2014;46(5):1444–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Antunes M, Teixeira A, Fortuna P, Moya B, Martins A, Bagulho L, et al. Infections after liver transplantation: a retrospective, single-center study. Transplant Proc. 2015;47(4):1019–24.PubMedCrossRefGoogle Scholar
  81. 81.
    Kawecki D, Pacholczyk M, Lagiewska B, Sawicka-Grzelak A, Durlik M, Mlynarczyk G, et al. Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility. Transplant Proc. 2014;46(8):2777–81.PubMedCrossRefGoogle Scholar
  82. 82.
    Esfeh JM, Hanouneh IA, Koval CE, Kovacs C, Dalal DS, Ansari-Gilani K, et al. Impact of pretransplant rifaximin therapy on early post-liver transplant infections. Liver Transpl. 2014;20(5):544–51.PubMedCrossRefGoogle Scholar
  83. 83.
    Sanchez CL, Len O, Gavalda J, Bilbao I, Castells L, Gelabert MA, et al. Liver biopsy-related infection in liver transplant recipients: a current matter of concern? Liver Transpl. 2014;20(5):552–6.PubMedCrossRefGoogle Scholar
  84. 84.
    Wong NA, Bathgate AJ, Bellamy CO. Colorectal disease in liver allograft recipients—a clinicopathological study with follow-up. Eur J Gastroenterol Hepatol. 2002;14(3):231–6.PubMedCrossRefGoogle Scholar
  85. 85.
    Razonable RR. Cytomegalovirus infection after liver transplantation: current concepts and challenges. World J Gastroenterol. 2008;14(31):4849–60.PubMedCentralPubMedCrossRefGoogle Scholar
  86. 86.
    Arthurs SK, Eid AJ, Pedersen RA, Dierkhising RA, Kremers WK, Patel R, et al. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl. 2007;13(12): 1703–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Jain A, Orloff M, Kashyap R, Lansing K, Betts R, Mohanka R, et al. Does valganciclovir hydrochloride (Valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients? Transplant Proc. 2005;37(7):3182–6.PubMedCrossRefGoogle Scholar
  88. 88.
    Vivarelli M, De Ruvo N, Lazzarotto T, Bellusci R, Landini MP, Varani S, et al. Abstension from treatment of low-level pp 65 cytomegalovirus antigenemia after liver transplantation: a prospective study. Transplantation. 2000;70(8):1183–7.PubMedCrossRefGoogle Scholar
  89. 89.
    Lautenschlager I, Halme L, Hockerstedt K, Krogerus L, Taskinen E. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations. Transpl Infect Dis. 2006;8(1):21–30.PubMedCrossRefGoogle Scholar
  90. 90.
    Hoffman JA. Adenoviral disease in pediatric solid organ transplant recipients. Pediatr Transplant. 2006;10(1):17–25.PubMedCrossRefGoogle Scholar
  91. 91.
    Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5:262–74.PubMedCentralPubMedCrossRefGoogle Scholar
  92. 92.
    McLaughlin GE, Delis S, Kashimawo L, Cantwell GP, Mittal N, Cirocco RE, et al. Adenovirus infection in pediatric liver and intestinal transplant recipients: utility of DNA detection by PCR. Am J Transplant. 2003;3(2):224–8.PubMedCrossRefGoogle Scholar
  93. 93.
    Sganga G, Bianco G, Frongillo F, Lirosi MC, Nure E, Agnes S. Fungal infections after liver transplantation: incidence and outcome. Transplant Proc. 2014;46(7):2314–8.PubMedCrossRefGoogle Scholar
  94. 94.
    Raghuram A, Restrepo A, Safadjou S, Cooley J, Orloff M, Hardy D, et al. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007). Liver Transpl. 2012;18(9):1100–9.PubMedCrossRefGoogle Scholar
  95. 95.
    Shi S-H, Lu A-W, Shen Y, Jia C-K, Wang W-L, Xie H-Y, et al. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Chin Med J (Engl). 2008;121(7):625–30.Google Scholar
  96. 96.
    Alexander J, Limaye AP, Ko CW, Bronner MP, Kowdley K. Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver Transpl. 2006;12:1799–804.PubMedCrossRefGoogle Scholar
  97. 97.
    Saliba F, Pascher A, Cointault O, Laterre PF, Cervera C, De Waele JJ, et al. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients. Clin Infect Dis. 2015;60(7):997–1006.PubMedGoogle Scholar
  98. 98.
    Winston DJ, Limaye AP, Pelletier S, Safdar N, Morris MI, Meneses K, et al. Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. Am J Transplant. 2014;14(12):2758–64.PubMedCrossRefGoogle Scholar
  99. 99.
    Maurer JR. The spectrum of colonic complications in a lung transplant population. Ann Transplant. 2000;5(3):54–7.PubMedGoogle Scholar
  100. 100.
    Bravo C, Gispert P, Borro JM, de la Torre M, Cifrian Martinez JM, Fernandez Rozas S, et al. Prevalence and management of gastrointestinal complications in lung transplant patients: MITOS study group. Transplant Proc. 2007;39(7):2409–12.PubMedCrossRefGoogle Scholar
  101. 101.
    Diaz B, Gonzalez Vilchez F, Almenar L, Delgado JF, Manito N, Paniagua MJ, MITOS Study Group, et al. Gastrointestinal complications in heart transplant patients: MITOS study. Transplant Proc. 2007;39:2397–400.PubMedCrossRefGoogle Scholar
  102. 102.
    Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant. 2003;17(4):363–8.PubMedCrossRefGoogle Scholar
  103. 103.
    Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest. 2003;124(5):1689–93.PubMedCrossRefGoogle Scholar
  104. 104.
    Berkowitz N, Schulman LL, McGregor C, Markowitz D. Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications. Chest. 1995;108(6):1602–7.PubMedCrossRefGoogle Scholar
  105. 105.
    Sodhi SS, Guo JP, Maurer AH, O'Brien G, Srinivasan R, Parkman HP. Gastroparesis after combined heart and lung transplantation. J Clin Gastroenterol. 2002;34(1):34–9.PubMedCrossRefGoogle Scholar
  106. 106.
    Verleden GM, Besse T, Maes B. Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. Transplantation. 2002;73(12):1974–6.PubMedCrossRefGoogle Scholar
  107. 107.
    Lau CL, Palmer SM, Howell DN, McMahon R, Hadjiliadis D, Gaca J, et al. Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc. 2002;16(12):1674–8.PubMedCrossRefGoogle Scholar
  108. 108.
    Davis Jr RD, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg. 2003;125(3):533–42.PubMedCrossRefGoogle Scholar
  109. 109.
    Curling TB. On acute ulceration of the duodenum in cases of burn. Med Chir Trans. 1842;25:260–81.PubMedCentralPubMedCrossRefGoogle Scholar
  110. 110.
    Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther. 2004;26(2):197–213.PubMedCrossRefGoogle Scholar
  111. 111.
    Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg. 1998;116(4): 617–23.PubMedCrossRefGoogle Scholar
  112. 112.
    Kemnitz J, Cremer J, Gebel M, Uysal A, Haverich A, Georgii A. T-cell lymphoma after heart transplantation. Am J Clin Pathol. 1990;94:95–101.PubMedCrossRefGoogle Scholar
  113. 113.
    Gilljam M, Chaparro C, Tullis E, Chan C, Keshavjee S, Hutcheon M. GI complications after lung transplantation in patients with cystic fibrosis. Chest. 2003;123(1):37–41.PubMedCrossRefGoogle Scholar
  114. 114.
    Sekela ME, Hutchins DA, Young JB, Noon GP. Biliary surgery after cardiac transplantation. Arch Surg. 1991;126: 571–3.PubMedCrossRefGoogle Scholar
  115. 115.
    Abu-Elmagd K, Reyes J, Bond G, Mazariegos G, Wu T, Murase N, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg. 2001;234(3):404–16. discussion 16–7.PubMedCentralPubMedCrossRefGoogle Scholar
  116. 116.
    Ziring D, Tran R, Edelstein S, McDiarmid SV, Gajjar N, Cortina G, et al. Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation. 2005;79(6):702–9.PubMedCrossRefGoogle Scholar
  117. 117.
    Pinchoff RJ, Kaufman SS, Magid MS, Erdman DD, Gondolesi GE, Mendelson MH, et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation. 2003;76(1):183–9.PubMedCrossRefGoogle Scholar
  118. 118.
    Berho M, Torroella M, Viciana A, Weppler D, Thompson J, Nery J, et al. Adenovirus enterocolitis in human small bowel transplants. Pediatr Transplant. 1998;2(4):277–82.PubMedGoogle Scholar
  119. 119.
    Kaufman SS, Chatterjee NK, Fuschino ME, Magid MS, Gordon RE, Morse DL, et al. Calicivirus enteritis in an intestinal transplant recipient. Am J Transplant. 2003;3(6):764–8.PubMedCrossRefGoogle Scholar
  120. 120.
    Tzakis AG. Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation. Transpl Infect Dis. 2001;2:35–9.CrossRefGoogle Scholar
  121. 121.
    Abu-Elmagd KM, Zak M, Stamos JM, Bond GJ, Jain A, Youk AO, et al. De novo malignancies after intestinal and multivisceral transplantation. Transplantation. 2004;77(11):1719–25.PubMedCrossRefGoogle Scholar
  122. 122.
    Chehade M, Nowak-Wegrzyn A, Kaufman SS, Fishbein TM, Tschernia A, LeLeiko NS. De novo food allergy after intestinal transplantation: a report of three cases. J Pediatr Gastroenterol Nutr. 2004;38(5):545–7.PubMedCrossRefGoogle Scholar
  123. 123.
    Hockenbery D, Strasser S, McDonald G. Gastrointestinal and hepatic complications. In: Appelbaum FR, Forman SJ, Negrin RS, Antin JH, editors. Thomas’ hematopoietic cell transplantation: stem cell transplantation. 5th ed. Hoboken, NJ: John Wiley & Sons Inc; 2015.Google Scholar
  124. 124.
    Fries BC, Riddell SR, Kim HW, Corey L, Dahlgren C, Woolfrey A, et al. Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation. Biol Blood Marrow Transplant. 2005;11(2): 136–48.PubMedCrossRefGoogle Scholar
  125. 125.
    Velasco Guardado A, Lopez-Corral L, Perez-Simon JA, Caballero-Velazquez T, Flores Corral T, Caballero Barrigon D, et al. Helicobacter pylori infection and graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17(5):765–9.PubMedCrossRefGoogle Scholar
  126. 126.
    Kang G, Srivastava A, Pulimood AB, Dennison D, Chandy M. Etiology of diarrhea in patients undergoing allogeneic bone marrow transplantation in South India. Transplantation. 2002;73(8):1247–51.PubMedCrossRefGoogle Scholar
  127. 127.
    Muller CI, Zeiser R, Grullich C, Finke J, Bertz H, Schmitt-Graff A, et al. Intestinal cryptosporidiosis mimicking acute graft-versus-host disease following matched unrelated hematopoietic stem cell transplantation. Transplantation. 2004;77(9):1478–9.PubMedCrossRefGoogle Scholar
  128. 128.
    Sebastian E, Martin J, McDonald GB, Flores T, Rodriguez A, Blanco A, et al. Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms. Bone Marrow Transplant. 2011;46(4):612–4.PubMedCrossRefGoogle Scholar
  129. 129.
    Schwartz S, Vergoulidou M, Schreier E, Loddenkemper C, Reinwald M, Schmidt-Hieber M, et al. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood. 2011; 117(22):5850–6.PubMedCrossRefGoogle Scholar
  130. 130.
    McLauchlin J, Amar CFL, Pedraza-Diaz S, Mieli-Vergani G, Hadzic N, Davies EG. Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficiencies. Pediatr Infect Dis J. 2003;22(4):329–35.PubMedGoogle Scholar
  131. 131.
    Dimicoli S, Bensoussan D, Latger-Cannard V, Straczek J, Antunes L, Mainard L, et al. Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome. Bone Marrow Transplant. 2003;32(7):733–7.PubMedCrossRefGoogle Scholar
  132. 132.
    McCullough KD, McDonald GB. Neutropenic enterocolitis. Curr Treatment Option Infect Dis. 2003;5:367–75.Google Scholar
  133. 133.
    Davila ML. Neutropenic enterocolitis: current issues in diagnosis and management. Curr Infect Dis Rep. 2007;9(2):116–20.PubMedCrossRefGoogle Scholar
  134. 134.
    Lehrnbecher T, Marshall D, Gao C, Chanock SJ. A second look at anorectal infections in cancer patients in a large cancer institute: the success of early intervention with antibiotics and surgery. Infection. 2002;30(5):272–6.PubMedCrossRefGoogle Scholar
  135. 135.
    Ryan C, De Gascun CF, Powell C, Sheahan K, Mooney EE, McCormick A, et al. Cytomegalovirus-induced cutaneous vasculopathy and perianal ulceration. J Am Acad Dermatol. 2011;64(6):1216–8.PubMedCrossRefGoogle Scholar
  136. 136.
    Strasser SI, McDonald GB. Gastrointestinal and hepatic complications. In: Forman SJ, Appelbaum FR, Blume KG, Negrin R, editors. Thomas’ hematopoietic cell transplantation. 4th ed. Malden, MA: Blackwell Publishing Inc; 2009.Google Scholar
  137. 137.
    von Bahr L, Blennow O, Alm J, Bjorklund A, Malmberg KJ, Mougiakakos D, et al. Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation. Bone Marrow Transplant. 2015;50(9):1217–23.CrossRefGoogle Scholar
  138. 138.
    Malone FR, Leisenring W, Schoch G, Stern J, Aker S, Lawler R, et al. Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant. Bone Marrow Transplant. 2007;40:765–72.PubMedCrossRefGoogle Scholar
  139. 139.
    Wu D, Hockenberry DM, Brentnall TA, Baehr PH, Ponec RJ, Kuver R, et al. Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. Transplantation. 1998;66(10):1319–24.PubMedCrossRefGoogle Scholar
  140. 140.
    Weisdorf SA, Salati LM, Longsdorf JA, Ramsay NK, Sharp HL. Graft-vs-host disease of the intestine: a protein-losing enteropathy characterized by fecal alpha1-antitrypsin. Gastroenterology. 1983;85:1076–81.PubMedGoogle Scholar
  141. 141.
    Cox GJ, Matsui SM, Lo RS, Hinds M, Bowden RA, Hackman RC, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology. 1994;107:1398–407.PubMedCrossRefGoogle Scholar
  142. 142.
    Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, et al. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2014;49(7):966–71.PubMedCentralPubMedCrossRefGoogle Scholar
  143. 143.
    Sakai M, McDonald GB. Gastrointestinal and hepatic manifestations of chronic GVHD. In: Vogelsang G, Pavletic S, editors. Chronic graft-versus-host disease principles and practice of interdisciplinary management. New York, NY: Cambridge University Press; 2008.Google Scholar
  144. 144.
    Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008;32(9):1367–72.PubMedCrossRefGoogle Scholar
  145. 145.
    Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012;55(7):905–14.PubMedCentralPubMedCrossRefGoogle Scholar
  146. 146.
    Ye X, Van JN, Munoz FM, Revell PA, Kozinetz CA, Krance RA, et al. Noroviruses as a cause of diarrhea in immunocompromised pediatric hematopoietic stem cell and solid organ transplant recipients. Am J Transplant. 2015;15(7):1874–81.PubMedCentralPubMedCrossRefGoogle Scholar
  147. 147.
    Zaia J, Baden L, Boeckh MJ, Chakrabarti S, Einsele H, Ljungman P, et al. Viral disease prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009;44(8): 471–82.PubMedCrossRefGoogle Scholar
  148. 148.
    van Burik JH, Leisenring W, Myerson D, Hackman RC, Shulman HM, Sale GE, et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis: an autopsy study of 355 patients. Medicine (Baltimore). 1998;77:246–54.CrossRefGoogle Scholar
  149. 149.
    Maertens J, Marchetti O, Herbrecht R, Cornely O, Flückiger U, Frere P, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 update. Bone Marrow Transplant. 2011;46(5):709–18.PubMedCrossRefGoogle Scholar
  150. 150.
    Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematology. 2011;25(1):151–69.Google Scholar
  151. 151.
    Boeckh M, Nichols WG, Chemaly RF, Papanicolaou GA, Wingard JR, Xie H, et al. Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial. Ann Intern Med. 2015;162(1):1–10.PubMedCentralPubMedCrossRefGoogle Scholar
  152. 152.
    Boeckh M, Murphy WJ, Peggs KS. Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biol Blood Marrow Transplant. 2015;21(1):24–9.PubMedCrossRefGoogle Scholar
  153. 153.
    Sonsino E, Mouy R, Foucaud P, Cezard JP, Aigrain Y, Bocquet L, et al. Intestinal pseudoobstruction related to cytomegalovirus infection of myenteric plexus (letter). N Engl J Med. 1984;311:196–7.PubMedGoogle Scholar
  154. 154.
    Baldwin A, Kingman H, Darville M, Foot AB, Grier D, Cornish JM, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant. 2000;26(12):1333–8.PubMedCrossRefGoogle Scholar
  155. 155.
    La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001;32(6): 871–6.PubMedCrossRefGoogle Scholar
  156. 156.
    Bruno B, Gooley T, Hackman RC, Davis C, Corey L, Boeckh M. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant. 2003;9(5):341–52.PubMedCrossRefGoogle Scholar
  157. 157.
    Muller WJ, Levin MJ, Shin YK, Robinson C, Quinones R, Malcolm J, et al. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis. 2005;41(12):1812–6.PubMedCrossRefGoogle Scholar
  158. 158.
    Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007;13(1):74–81.PubMedCrossRefGoogle Scholar
  159. 159.
    Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, et al. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Clin Infect Dis. 2013;57(6):794–802.PubMedCrossRefGoogle Scholar
  160. 160.
    Zutter MM, Durnam DM, Hackman RC, Loughran TPJ, Kidd PG, Ashley RL, et al. Secondary T-cell lymphoproliferation after marrow transplantation. Am J Clin Pathol. 1990;94:714–21.PubMedCrossRefGoogle Scholar
  161. 161.
    Collier AC, Miller RA, Meyers JD. Cryptosporidiosis after marrow transplantation: person-to-person transmission and treatment with spiramycin. Ann Intern Med. 1984;101:205–6.PubMedCrossRefGoogle Scholar
  162. 162.
    Bromiker R, Korman SH, Or R, Hardan I, Naparstek E, Cohen P, et al. Severe giardiasis in two patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1989;4:701–3.PubMedGoogle Scholar
  163. 163.
    McDonald GB, Sullivan KM, Schuffler MD, Shulman HM, Thomas ED. Esophageal abnormalities in chronic graft-versus-host disease in humans. Gastroenterology. 1981;80: 914–21.PubMedGoogle Scholar
  164. 164.
    Minocha A, Mandanas RA, Kida M, Jazzar A. Bullous esophagitis due to chronic graft-versus-host disease. Am J Gastroenterol. 1997;92:529–30.PubMedGoogle Scholar
  165. 165.
    Patey-Mariaud De Serre N, Reijasse D, Verkarre V, Canioni D, Colomb V, Haddad E, et al. Chronic intestinal graft-versus-host disease: clinical, histological and immunohistochemical analysis of 17 children. Bone Marrow Transplant. 2002;29:223–30.PubMedCrossRefGoogle Scholar
  166. 166.
    Akpek G, Chinratanalab W, Lee LA, Torbenson M, Hallick JP, Anders V, et al. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transpl. 2003;1:46–51.CrossRefGoogle Scholar
  167. 167.
    Yuen KY, Woo PC, Liang RH, Chiu EK, Chen FF, Wong SS, et al. Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn Microbiol Infect Dis. 1998;30(2):75–81.PubMedCrossRefGoogle Scholar
  168. 168.
    Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant. 2005;36:115–21.PubMedCrossRefGoogle Scholar
  169. 169.
    Borgaonkar MR, Duggan PR, Adams G. Differing clinical manifestations of celiac disease transmitted by bone marrow transplantation. Dig Dis Sci. 2006;51(1):210–2.PubMedCrossRefGoogle Scholar
  170. 170.
    Sonwalkar SA, James RM, Ahmad T, Zhang L, Verbeke CS, Barnard DL, et al. Fulminant Crohn’s colitis after allogeneic stem cell transplantation. Gut. 2003;52(10):1518–21.PubMedCentralPubMedCrossRefGoogle Scholar
  171. 171.
    Akpek G, Valladares JL, Lee L, Margolis J, Vogelsang GB. Pancreatic insufficiency in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2001;27:163–6.PubMedCrossRefGoogle Scholar
  172. 172.
    Vindigni SM, Surawicz CM. The gut microbiome: a clinically significant player in transplantation? Expert Rev Clin Immunol. 2015;11(7):781–3.PubMedCrossRefGoogle Scholar
  173. 173.
    Grat M, Holowko W, Galecka M, Grat K, Szachtaz P, Lewandowsk Z, et al. Gut microbiota in cirrhotic liver transplant candidates. Hepatogastroenterology. 2014;61(134):1661–7.PubMedGoogle Scholar
  174. 174.
    Chassaing B, Etienne-Mesmin L, Gewirtz AT. Microbiota-liver axis in hepatic disease. Hepatology. 2014;59(1):328–39.PubMedCrossRefGoogle Scholar
  175. 175.
    Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol. 2015;5 Suppl 1:S29–36.PubMedCrossRefGoogle Scholar
  176. 176.
    Zhang Y, Chen J, Wu J, Chalson H, Merigan L, Mitchell A. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg Nutr. 2013;2(3): 142–7.PubMedCentralPubMedGoogle Scholar
  177. 177.
    Lee JR, Muthukumar T, Dadhania D, Taur Y, Jenq RR, Toussaint NC, et al. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One. 2015;10(3):e0122399.PubMedCentralPubMedCrossRefGoogle Scholar
  178. 178.
    Bartman C, Chong AS, Alegre ML. The influence of the microbiota on the immune response to transplantation. Curr Opin Organ Transplant. 2015;20(1):1–7.PubMedCentralPubMedCrossRefGoogle Scholar
  179. 179.
    Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K, et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(5):640–5.PubMedCentralPubMedCrossRefGoogle Scholar
  180. 180.
    Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun. 2008;76(10):4726–36.PubMedCentralPubMedCrossRefGoogle Scholar
  181. 181.
    Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124(7):1174–82.PubMedCentralPubMedCrossRefGoogle Scholar
  182. 182.
    Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med. 2012;209(5):903–11.PubMedCentralPubMedCrossRefGoogle Scholar
  183. 183.
    Sekirov I, Finlay BB. The role of the intestinal microbiota in enteric infection. J Physiol. 2009;587(17):4159–67.PubMedCentralPubMedCrossRefGoogle Scholar
  184. 184.
    Kuhn KA, Pedraza I, Demoruelle MK. Mucosal immune responses to microbiota in the development of autoimmune disease. Rheum Dis Clin N Am. 2014;40(4):711–25.CrossRefGoogle Scholar
  185. 185.
    Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology. 1994;106:509–32.PubMedCrossRefGoogle Scholar
  186. 186.
    Rubin RH. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant-induced gastrointestinal toxicities. Clin Transplant. 2001;4:11–22.CrossRefGoogle Scholar
  187. 187.
    Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997;24:369–74.PubMedCrossRefGoogle Scholar
  188. 188.
    Anderson LI, Frederiksen HJ, Appleyard M. Prevalence of esophageal Candida colonization in a Danish population, with special reference to esophageal symptoms, benign esophageal disorders, and pulmonary disease. J Infect Dis. 1992;165:389.CrossRefGoogle Scholar
  189. 189.
    Hackman RC, Wolford JL, Gleaves CA, Myerson D, Beauchamp MD, Meyers JD, et al. Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods. Transplantation. 1994;57:231–7.PubMedCrossRefGoogle Scholar
  190. 190.
    Walsh TJ, Belitsos NJ, Hamilton SR. Bacterial esophagitis in immunocompromised patients. Arch Intern Med. 1986;146: 1345–9.PubMedCrossRefGoogle Scholar
  191. 191.
    Gordon AH, Marshall JB. Esophageal tuberculosis: definitive diagnosis by endoscopy. Am J Gastroenterol. 1990;85:174.PubMedGoogle Scholar
  192. 192.
    Augustine SM, Yeo CJ, Buchman TG, Achuff SC, Baumgartner WA. Gastrointestinal complications in heart and in heart-lung transplant patients. J Heart Lung Transpl. 1991;10(4):547–55. discussion 55–6.Google Scholar
  193. 193.
    Reed EC, Wolford JL, Kopecky KJ, Lilleby KE, Dandliker PS, Todaro JL, et al. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. Ann Intern Med. 1990;112: 505–10.PubMedCrossRefGoogle Scholar
  194. 194.
    Yagi T, Karasuno T, Hasegawa T, Yasumi M, Kawamoto S, Murakami M, et al. Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir. Bone Marrow Transplant. 2000;25(9):1003–5.PubMedCrossRefGoogle Scholar
  195. 195.
    Arabia FA, Rosado LJ, Huston CL, Sethi GK, Copeland III JG. Incidence and recurrence of gastrointestinal cytomegalovirus infection in heart transplantation. Ann Thorac Surg. 1993;55:8–11.PubMedCrossRefGoogle Scholar
  196. 196.
    Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, et al. Liver transplant-associated graft-versus-host disease. Transplantation. 2003;75(1):118–26.PubMedCrossRefGoogle Scholar
  197. 197.
    Assi MA, Pulido JS, Peters SG, McCannel CA, Razonable RR. Graft-vs.-host disease in lung and other solid organ transplant recipients. Clin Transplant. 2007;21(1):1–6.PubMedCrossRefGoogle Scholar
  198. 198.
    Gulbahce HE, Brown CA, Wick M, Segall M, Jessurun J. Graft-vs-host disease after solid organ transplant. Am J Clin Pathol. 2003;119(4):568–73.PubMedCrossRefGoogle Scholar
  199. 199.
    Ponec RJ, Hackman RC, McDonald GB. Endoscopic and histologic diagnosis of intestinal graft-vs.-host disease after marrow transplantation. Gastrointest Endosc. 1999;49:612–21.PubMedCrossRefGoogle Scholar
  200. 200.
    Holmberg L, Kikuchi K, Gooley TA, Adams KM, Hockenbery DM, Flowers MED, et al. Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. Biol Blood Marrow Transpl. 2006;12(2):226–34.CrossRefGoogle Scholar
  201. 201.
    Spencer GD, Hackman RC, McDonald GB, Amos DE, Cunningham BA, Meyers JD, et al. A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation. 1986;42:602–7.PubMedCrossRefGoogle Scholar
  202. 202.
    Eagle DA, Gian V, Lauwers GY, Manivel JC, Moreb JS, Mastin S, et al. Gastroparesis following bone marrow transplantation. Bone Marrow Transplant. 2001;28(1):59–62.PubMedCrossRefGoogle Scholar
  203. 203.
    Brand RE, DiBaise JK, Quigley EM, Gobar LS, Harmon KS, Lynch JC, et al. Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation. Lancet. 1998;352(9145):1985. see comments.PubMedCrossRefGoogle Scholar
  204. 204.
    DiBaise JK, Lyden E, Tarantolo SR, Bierman PJ, Brand RE. A prospective study of gastric emptying and its relationship to the development of nausea, vomiting, and anorexia after autologous stem cell transplantation. Am J Gastroenterol. 2005;100(7):1571–7.PubMedCrossRefGoogle Scholar
  205. 205.
    Pescovitz MD, Navarro MT. Immunosuppressive therapy and post-transplantation diarrhea. Clin Transplant. 2001;4:23–8.CrossRefGoogle Scholar
  206. 206.
    Rampling A, Warren RE, Berry PJ, Swirsky D, Hoggarth CE, Bevan PC. Atypical Clostridium difficile colitis in neutropenic patients (letter). Lancet. 1982;2:162–3.PubMedCrossRefGoogle Scholar
  207. 207.
    Gorschluter M, Glasmacher A, Hahn C, Schakowski F, Ziske C, Molitor E, et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis. 2001;33(6):786–91.PubMedCrossRefGoogle Scholar
  208. 208.
    Gellad ZF, Alexander BD, Liu JK, Griffith BC, Meyer AM, Johnson JL, et al. Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients. Transpl Infect Dis. 2007;9(4):276–80.PubMedCrossRefGoogle Scholar
  209. 209.
    Keven K, Basu A, Re L, Tan H, Marcos A, Fung JJ, et al. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis. 2004;6(1):10–4.PubMedCentralPubMedCrossRefGoogle Scholar
  210. 210.
    Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer. 2000;8(6): 504–5.PubMedCrossRefGoogle Scholar
  211. 211.
    Dubberke ER, Gerding DN, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S81–92.PubMedCrossRefGoogle Scholar
  212. 212.
    Muto CA, Blank MK, Marsh JW, Vergis EN, O'Leary MM, Shutt KA, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis. 2007;45(10):1266–73.PubMedCrossRefGoogle Scholar
  213. 213.
    Bhatt AS, Freeman SS, Herrera AF, Pedamallu CS, Gevers D, Duke F, et al. Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med. 2013;369(6): 517–28.PubMedCentralPubMedCrossRefGoogle Scholar
  214. 214.
    Gorkiewicz G, Trajanoski S, Hogenauer C. Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med. 2013;369(19):1866–7.PubMedCrossRefGoogle Scholar
  215. 215.
    Herrera AF, Soriano G, Bellizzi AM, Hornick JL, Ho VT, Ballen KK, et al. Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J Med. 2011;365(9):815–24.PubMedCrossRefGoogle Scholar
  216. 216.
    Gupta NK, Masia R. Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract. Am J Surg Pathol. 2013;37(7):1109–13.PubMedCentralPubMedCrossRefGoogle Scholar
  217. 217.
    Matuchansky C. Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J Med. 2011;365(24):2336–7. author reply 7–8.PubMedCrossRefGoogle Scholar
  218. 218.
    Milano F, Shulman HM, Guthrie KA, Riffkin I, McDonald GB, Delaney C. Late-onset colitis after cord blood transplantation is consistent with graft-versus-host disease: results of a blinded histopathological review. Biol Blood Marrow Transplant. 2014;20(7):1008–13.PubMedCrossRefGoogle Scholar
  219. 219.
    Anonymous. Clostridium septicum infection and neutropenic enterocolitis (editorial). Lancet. 1987;2:608.Google Scholar
  220. 220.
    Cordonnier C, Martino R, Trabasso P, Held TK, Akan H, Ward MS, et al. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis. 2004;38(9):1229–36.PubMedCrossRefGoogle Scholar
  221. 221.
    Nicholson O, Feja K, LaRussa P, George D, Unal E, Della Latta P, et al. Nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplant recipients: case report and review of the literature. Pediatr Infect Dis J. 2006;25(3):263–7.PubMedCrossRefGoogle Scholar
  222. 222.
    Fang GD, Yu VL, Vickers RM. Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemiological review. [erratum appears in Medicine (Baltimore) 1989;68(4):209].Google Scholar
  223. 223.
    Spencer GD, Shulman HM, Myerson D, Thomas ED, McDonald GB. Diffuse intestinal ulceration after marrow transplantation: a clinical-pathological study of 13 patients. Hum Pathol. 1986;17:621–33.PubMedCrossRefGoogle Scholar
  224. 224.
    Tajima T. An autopsy case of primary cytomegalic inclusion enteritis with remarkable hypoproteinemia. Acta Pathol Jpn. 1974;24:151–62.PubMedGoogle Scholar
  225. 225.
    Underwood JCE, Corbett CL. Persistent diarrhea and hypoalbuminemia associated with cytomegalovirus enteritis. Br Med J. 1978;1:1029–30.PubMedCentralPubMedCrossRefGoogle Scholar
  226. 226.
    Remzi FH. Colonic complications of organ transplantation. Transplant Proc. 2002;34(6):2119–21.PubMedCrossRefGoogle Scholar
  227. 227.
    Lewis-Jones HG, Ward RG, Garvey C. Cytomegalovirus infection masquerading as colonic neoplasia. Br J Radiol. 1990;63:573–4.PubMedCrossRefGoogle Scholar
  228. 228.
    van Burik JA, Lawatsch EJ, DeFor TE, Weisdorf DJ. Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transpl. 2001;7(12): 674–9.CrossRefGoogle Scholar
  229. 229.
    Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, et al. Cytomegalovirus in transplantation—challenging the status quo. Clin Transplant. 2007;21(2): 149–58.PubMedCrossRefGoogle Scholar
  230. 230.
    Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med. 1985;312: 529–33.PubMedCrossRefGoogle Scholar
  231. 231.
    Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis. 2003;3(2):79–86.PubMedCrossRefGoogle Scholar
  232. 232.
    Michaels MG, Green M, Wald ER, Starzl TE. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis. 1992;165:170–4.PubMedCentralPubMedCrossRefGoogle Scholar
  233. 233.
    Lion T, Kosulin K, Landlinger C, Rauch M, Preuner S, Jugovic D, et al. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia. 2010;24(4):706–14.PubMedCrossRefGoogle Scholar
  234. 234.
    Anderson EJ, Guzman-Cottrill JA, Kletzel M, Thormann K, Sullivan C, Zheng X, et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant. 2008;12(2):219–27.PubMedCrossRefGoogle Scholar
  235. 235.
    Leruez-Ville M, Chardin-Ouachee M, Neven B, Picard C, Le Guinche I, Fischer A, et al. Description of an adenovirus A31 outbreak in a paediatric haematology unit. Bone Marrow Transplant. 2006;38(1):23–8.PubMedCrossRefGoogle Scholar
  236. 236.
    Mattner F, Sykora KW, Meissner B, Heim A. An adenovirus type F41 outbreak in a pediatric bone marrow transplant unit: analysis of clinical impact and preventive strategies. Pediatr Infect Dis J. 2008;27(5):419–24.PubMedCrossRefGoogle Scholar
  237. 237.
    Ljungman P. Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis. 2004;23(8):583–8.PubMedCrossRefGoogle Scholar
  238. 238.
    Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transplant. 2009;44(8):453–5.PubMedCrossRefGoogle Scholar
  239. 239.
    Humar A, Kumar D, Mazzulli T, Razonable RR, Moussa G, Paya CV, et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant. 2005;5(10):2555–9.PubMedCrossRefGoogle Scholar
  240. 240.
    Willoughby RE, Wee SB, Yolken RH. Non-group A rotavirus infection associated with severe gastroenteritis in a bone marrow tranplant patient. Pediatr Infect Dis J. 1988;7:133–5.PubMedCrossRefGoogle Scholar
  241. 241.
    Sebire NJ, Malone M, Shah N, Anderson G, Gaspar HB, Cubitt WD. Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient. J Clin Pathol. 2004;57(9):1001–3.PubMedCentralPubMedCrossRefGoogle Scholar
  242. 242.
    Rodriguez-Baez N, O'Brien R, Qiu SQ, Bass DM. Astrovirus, adenovirus, and rotavirus in hospitalized children: prevalence and association with gastroenteritis. J Pediatr Gastroenterol Nutr. 2002;35(1):64–8.PubMedCrossRefGoogle Scholar
  243. 243.
    Kamboj M, Mihu CN, Sepkowitz K, Kernan NA, Papanicolaou GA. Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield. Transpl Infect Dis. 2007;9(4):265–9.PubMedCrossRefGoogle Scholar
  244. 244.
    Liakopoulou E, Mutton K, Carrington D, Robinson S, Steward CG, Goulden NJ, et al. Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant. 2005;36(8):691–4.PubMedCrossRefGoogle Scholar
  245. 245.
    Stelzmueller I, Wiesmayr S, Swenson BR, Biebl M, Goegele H, Margreiter R, et al. Rotavirus enteritis in solid organ transplant recipients: an underestimated problem? Transpl Infect Dis. 2007;9(4):281–5.PubMedCrossRefGoogle Scholar
  246. 246.
    Fitts SW, Green M, Reyes J, Nour B, Tzakis AG, Kocoshis SA. Clinical features of nosocomial rotavirus infection in pediatric liver transplant recipients. Clin Transplant. 1995;9(3 Pt 1):201–4.PubMedGoogle Scholar
  247. 247.
    Stelzmueller I, Dunst KM, Hengster P, Wykypiel H, Steurer W, Wiesmayr S, et al. A cluster of rotavirus enteritis in adult transplant recipients. Transpl Int. 2005;18(4):470–4.PubMedCrossRefGoogle Scholar
  248. 248.
    Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, Koopmans M. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect. 2006;12(1):69–74.PubMedCrossRefGoogle Scholar
  249. 249.
    Kaufman SS, Chatterjee NK, Fuschino ME, Morse DL, Morotti RA, Magid MS, et al. Characteristics of human calicivirus enteritis in intestinal transplant recipients. J Pediatr Gastroenterol Nutr. 2005;40(3):328–33.PubMedCrossRefGoogle Scholar
  250. 250.
    Danna PL, Urban C, Bellin E, Rahal JJ. Role of candida in pathogenesis of antibiotic-associated diarrhea in elderly patients. Lancet. 1991;337:511–4.PubMedCrossRefGoogle Scholar
  251. 251.
    Prescott RJ, Harris M, Banerjee SS. Fungal infections of the small and large intestine. J Clin Pathol. 1992;45:806–11.PubMedCentralPubMedCrossRefGoogle Scholar
  252. 252.
    Pinto-Marques P, Hockenbery DM, Hackman RC, Tapper D, McDonald GB. Successful medical treatment of intestinal ulceration caused by Rhizopus microsporus. Bone Marrow Transplant. 2003;32(7):739–40.PubMedCrossRefGoogle Scholar
  253. 253.
    Sing A, Tybus K, Heesemann J, Mathis A. Molecular diagnosis of an Enterocytozoon bieneusi human genotype C infection in a moderately immunosuppressed human immunodeficiency virus seronegative liver-transplant recipient with severe chronic diarrhea. J Clin Microbiol. 2001;39(6):2371–2. Review [5 refs].PubMedCentralPubMedCrossRefGoogle Scholar
  254. 254.
    Goetz M, Eichenlaub S, Pape GR, Hoffmann RM. Chronic diarrhea as a result of intestinal microsporidiosis in a liver transplant recipient. Transplantation. 2001;71(2):334–7.PubMedCrossRefGoogle Scholar
  255. 255.
    Rabodonirina M, Bertocchi M, Desportes-Livage I, Cotte L, Levrey H, Piens MA, et al. Enterocytozoon bieneusi as a cause of chronic diarrhea in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus. Clin Infect Dis. 1996;23(1):114–7. see comments.PubMedCrossRefGoogle Scholar
  256. 256.
    Guerard A, Rabodonirina M, Cotte L, Liguory O, Piens MA, Daoud S, et al. Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil. Transplantation. 1999;68(5):699–707.PubMedCrossRefGoogle Scholar
  257. 257.
    Mittal N, Thompson JF, Kato T, Tzakis AG. Tacrolimus and diarrhea: pathogenesis of altered metabolism. Pediatr Transplant. 2001;5(2):75–9. letter; comment.PubMedCrossRefGoogle Scholar
  258. 258.
    Eades SK, Boineau FG, Christensen ML. Increased tacrolimus levels in a pediatric renal transplant patient attributed to chronic diarrhea. Pediatr Transplant. 2000;4(1):63–6.PubMedCrossRefGoogle Scholar
  259. 259.
    Hardinger KL, Hebbar S, Bloomer T, Murillo D. Adverse drug reaction driven immunosuppressive drug manipulations: a single-center comparison of enteric-coated mycophenolate sodium vs. mycophenolate mofetil. Clin Transplant. 2008;22: 555–61.PubMedCrossRefGoogle Scholar
  260. 260.
    Kaplan B, Meier-Kriesche HU, Jacobs MG, Friedman G, Bonomini L, DeFranco P, et al. Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain. Am J Kidney Dis. 1999;34(1):65–8.PubMedCrossRefGoogle Scholar
  261. 261.
    Hoekstra HJ, Hawkins K, de Boer WJ, Rottier K, van der Bij W. Gastrointestinal complications in lung transplant survivors that require surgical intervention. Br J Surg. 2001;88(3):433–8.PubMedCrossRefGoogle Scholar
  262. 262.
    Zainudin BM, Kassim F, Annuar NM, Lim CS, Ghazali AK, Murad Z. Disseminated histoplasmosis presenting with ileal perforation in a renal transplant recipient. J Trop Med Hygiene. 1992;95:276–9.Google Scholar
  263. 263.
    Dominguez Fernandez E, Albrecht KH, Heemann U, Kohnle M, Erhard J, Stoblen F, et al. Prevalence of diverticulosis and incidence of bowel perforation after kidney transplantation in patients with polycystic kidney disease. Transpl Int. 1998;11(1):28–31.PubMedCrossRefGoogle Scholar
  264. 264.
    Nomdedeu JF, Nomdedeu J, Martino R, Bordes R, Portorreal R, Sureda A, et al. Ogilvie’s syndrome from disseminated varicella-zoster infection and infarcted celiac ganglia. J Clin Gastroenterol. 1995;20:157–9.PubMedCrossRefGoogle Scholar
  265. 265.
    Grant RM, Weitzman SS, Sherman CG, Sirkin WL, Petric M, Tellier R. Fulminant disseminated Varicella Zoster virus infection without skin involvement. J Clin Virol. 2002;24(1–2):7–12.PubMedCrossRefGoogle Scholar
  266. 266.
    Yong S, Attal H, Chejfec G. Pseudomembranous gastritis: a novel complication of Aspergillus infection in a patient with a bone marrow transplant and graft versus host disease. Arch Pathol Lab Med. 2000;124(4):619–24.PubMedGoogle Scholar
  267. 267.
    Cartoni C, Dragoni F, Micozzi A, Pescarmona E, Mecarocci S, Chirletti P, et al. Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol. 2001;19(3):756–61.PubMedCrossRefGoogle Scholar
  268. 268.
    Schlatter M, Snyder K, Freyer D. Successful nonoperative management of typhlitis in pediatric oncology patients. J Pediatr Surg. 2002;37(8):1151–5.PubMedCrossRefGoogle Scholar
  269. 269.
    Baerg J, Murphy JJ, Anderson R, Magee JF. Neutropenic enteropathy: a 10-year review. J Pediatr Surg. 1999; 34(7):1068–71.PubMedCrossRefGoogle Scholar
  270. 270.
    Wahbeh G, Hupertz V, Hallowell S, Patel R, Chrisant MR. Idiopathic colitis following cardiac transplantation: three pediatric cases. Pediatr Transplant. 2003;7(6):464–8.PubMedCrossRefGoogle Scholar
  271. 271.
    Knechtle SJ, Davidoff AM, Rice RP. Pneumatosis intestinalis. Surgical management and clinical outcome. Ann Surg. 1990;212:160–5.PubMedCentralPubMedCrossRefGoogle Scholar
  272. 272.
    Glenn J, Cotton D, Wesley R, Pizzo P. Anorectal infections in patients with malignant disease. Rev Infect Dis. 1988;16: 42–52.CrossRefGoogle Scholar
  273. 273.
    Corfitsen MT, Hansen CP, Christensen TH, Kaae HH. Anorectal abscesses in immunosuppressed patients. Eur J Surg. 1992;158(1):51–3.PubMedGoogle Scholar
  274. 274.
    Kalb RE, Grossman ME. Chronic perianal herpes simplex in immunocompromised hosts. Am J Med. 1986;80:486–90.PubMedCrossRefGoogle Scholar
  275. 275.
    Schwartz JM, Wolford JL, Thornquist MD, Hockenbery DM, Murakami CS, Drennan F, et al. Severe gastrointestinal bleeding after marrow transplantation, 1987-1997: incidence, causes, and outcome. Am J Gastroenterol. 2001;96:385–93.PubMedGoogle Scholar
  276. 276.
    Dummer JS, White LT, Ho M, Griffith BP, Hardesty RL, Bahnson HT. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis. 1985;152(6):1182–91.PubMedCrossRefGoogle Scholar
  277. 277.
    Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med. 1987;106(2):209–16.PubMedCrossRefGoogle Scholar
  278. 278.
    In: Kahan BD, Ponticelli C, editors. 1 ed., London: Martin Dunitz Ltd.; 2000.Google Scholar
  279. 279.
    Rattner HM, Cooper DJ, Zaman MB. Severe bleeding from herpes esophagitis. Am J Gastroenterol. 1985;80:523.PubMedGoogle Scholar
  280. 280.
    Stylianos S, Chen MH, Treat MR, LoGerfo P, Rose EA. Colonic lymphoma as a cause of massive rectal bleeding in a cardiac transplant recipient. J Cardiovasc Surg. 1990;31: 315–7.Google Scholar
  281. 281.
    Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood. 1988;72:520–9.PubMedGoogle Scholar
  282. 282.
    Kornbluth AA, Danzig JB, Bernstein LH. Clostridium septicum infection and associated malignancy. Report of 2 cases and review of the literature. Medicine (Baltimore). 1989;68:30–7.CrossRefGoogle Scholar
  283. 283.
    Nevo S, Swan V, Enger C. Acute bleeding after bone marrow transplantation (BMT)-incidence and effect on survival. A quantitative analysis in 1402 patients. Blood. 1998;91: 1469–77.PubMedGoogle Scholar
  284. 284.
    Selinger RRE, McDonald GB, Hockenbery DM, Steinbach G, Kimmey MB. Efficacy of neodymium: YAG laser therapy for gastric antral vascular ectasia (GAVE) following hematopoietic cell transplant. Bone Marrow Transplant. 2006;37(2): 191–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Open Access This chapter is distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Authors and Affiliations

  • Christopher J. Damman
    • 1
  • George B. McDonald
    • 2
    • 3
    • 4
    • 5
  1. 1.Gastroenterology/Hepatology Section, Fred Hutchinson Cancer Research CenterUniversity of Washington School of MedicineSeattleUSA
  2. 2.Professor of Medicine, University of Washington Member, Gastroenterology/Hepatology SectionClinical Research Division, Fred Hutchinson Cancer Research CenterSeattleUSA
  3. 3.Seattle Cancer Care AllianceUniversity of Washington Medical CenterSeattleUSA
  4. 4.Clinical Research DivisionFred Hutchinson Cancer Research CenterSeattleUSA
  5. 5.Department of Medicine, Gastroenterology/Hepatology Section (D5-114), Fred Hutchinson Cancer Research CenterUniversity of Washington School of MedicineSeattleUSA

Personalised recommendations